These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 19954689)
1. MRSA and diabetic foot wounds: contaminating or infecting organisms? Bowling FL; Jude EB; Boulton AJ Curr Diab Rep; 2009 Dec; 9(6):440-4. PubMed ID: 19954689 [TBL] [Abstract][Full Text] [Related]
2. Nasal MRSA carriage is a risk factor for development of antibiotic resistance in diabetic foot ulcers and is significantly higher than diabetic and non-diabetic individuals without foot ulcer. Mukherjee P; Paul S; Dutta T; Nath S; Ghosh B; Chatterjee D; Mukhopadhyay S; Mukherjee S BMC Infect Dis; 2023 Oct; 23(1):729. PubMed ID: 37884870 [TBL] [Abstract][Full Text] [Related]
3. Methicillin-resistant Staphylococcus aureus nasal carriage and infection among patients with diabetic foot ulcer. Lin SY; Lin NY; Huang YY; Hsieh CC; Huang YC J Microbiol Immunol Infect; 2020 Apr; 53(2):292-299. PubMed ID: 29907536 [TBL] [Abstract][Full Text] [Related]
4. Emergence of community-acquired methicillin-resistant Staphylococcus aureus EMRSA-15 clone as the predominant cause of diabetic foot ulcer infections in Portugal. Silva V; Almeida F; Carvalho JA; Castro AP; Ferreira E; Manageiro V; Tejedor-Junco MT; Caniça M; Igrejas G; Poeta P Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):179-186. PubMed ID: 31599357 [TBL] [Abstract][Full Text] [Related]
5. Utility of Methicillin-Resistant Staphylococcus aureus Nares Screening for Patients with a Diabetic Foot Infection. Mergenhagen KA; Croix M; Starr KE; Sellick JA; Lesse AJ Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988097 [TBL] [Abstract][Full Text] [Related]
6. [Risk factors for infections of methicillin-resistant Staphylococci in diabetic foot patients]. Ding Q; Li DQ; Wang PH; Chu YJ; Meng SY; Sun Q Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(4):228-31. PubMed ID: 22490791 [TBL] [Abstract][Full Text] [Related]
7. Virulence Potential of Staphylococcus aureus Strains Isolated from Diabetic Foot Ulcers Among Patients from Southern Poland. Pobiega M; Myjak I; Pomorska-Wesolowska M; Romaniszyn D; Ziolkowski G; Chmielarczyk A; Macig J; Szczypta A; Wójkowska-Mach J Curr Vasc Pharmacol; 2016; 14(6):547-551. PubMed ID: 27357184 [TBL] [Abstract][Full Text] [Related]
8. Invasive Systemic Infection After Hospital Treatment for Diabetic Foot Ulcer: Risk of Occurrence and Effect on Survival. Chen SY; Giurini JM; Karchmer AW Clin Infect Dis; 2017 Feb; 64(3):326-334. PubMed ID: 28013263 [TBL] [Abstract][Full Text] [Related]
9. Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Tentolouris N; Jude EB; Smirnof I; Knowles EA; Boulton AJ Diabet Med; 1999 Sep; 16(9):767-71. PubMed ID: 10510954 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology and prevalence of methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis in patients with diabetic foot ulcers: focus on the differences between species isolated from individuals with ischemic vs. neuropathic foot ulcers. Galkowska H; Podbielska A; Olszewski WL; Stelmach E; Luczak M; Rosinski G; Karnafel W Diabetes Res Clin Pract; 2009 May; 84(2):187-93. PubMed ID: 19269053 [TBL] [Abstract][Full Text] [Related]
11. [MRSA is spreading among diabetic patients: chronic wounds: El Dorado for problem pathogens]. MMW Fortschr Med; 2011 Oct; 153(42):26. PubMed ID: 22053442 [No Abstract] [Full Text] [Related]
12. Virulence determinants in clinical Staphylococcus aureus from monomicrobial and polymicrobial infections of diabetic foot ulcers. Shettigar K; Jain S; Bhat DV; Acharya R; Ramachandra L; Satyamoorthy K; Murali TS J Med Microbiol; 2016 Dec; 65(12):1392-1404. PubMed ID: 27902390 [TBL] [Abstract][Full Text] [Related]
13. Wound chronicity, inpatient care, and chronic kidney disease predispose to MRSA infection in diabetic foot ulcers. Yates C; May K; Hale T; Allard B; Rowlings N; Freeman A; Harrison J; McCann J; Wraight P Diabetes Care; 2009 Oct; 32(10):1907-9. PubMed ID: 19587371 [TBL] [Abstract][Full Text] [Related]
14. Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience. Lipsky BA; Cannon CM; Ramani A; Jandourek A; Calmaggi A; Friedland HD; Goldstein EJ Diabetes Metab Res Rev; 2015 May; 31(4):395-401. PubMed ID: 25417910 [TBL] [Abstract][Full Text] [Related]
16. Effect of daptomycin on local interleukin-6, matrix metalloproteinase-9, and metallopeptidase inhibitor 1 in patients with MRSA-infected diabetic foot. Ambrosch A; Halevy D; Fwity B; Brin T; Lobmann R Int J Low Extrem Wounds; 2014 Mar; 13(1):12-6. PubMed ID: 24659622 [TBL] [Abstract][Full Text] [Related]
17. An optimized mouse model of Staphylococcus aureus infected diabetic ulcers. Mendes AI; Peixoto MJ; Marques AP; Pedrosa J; Fraga AG BMC Res Notes; 2022 Sep; 15(1):293. PubMed ID: 36071445 [TBL] [Abstract][Full Text] [Related]
18. High Efficacy of Ozonated Oils on the Removal of Biofilms Produced by Methicillin-Resistant Silva V; Peirone C; Amaral JS; Capita R; Alonso-Calleja C; Marques-Magallanes JA; Martins Â; Carvalho Á; Maltez L; Pereira JE; Capelo JL; Igrejas G; Poeta P Molecules; 2020 Aug; 25(16):. PubMed ID: 32784722 [TBL] [Abstract][Full Text] [Related]